Greg Adamson

Greg Adamson is a Clinical Assistant Professor in the Department of Pediatrics - Cardiology at Stanford University School of Medicine and a member of the Maternal & Child Health Research Institute (MCHRI). He specializes in Interventional Cardiology and Lymphatic Diseases, with clinical expertise in managing conditions like chylothorax and pulmonary arterial hypertension.

• Medical Education: St. Louis University School of Medicine (2014)
• Residency: University of California San Francisco (2017)
• Fellowship: Stanford University Pediatric Cardiology Fellowship (2020)
• Board Certifications: Pediatrics (2017) and Pediatric Cardiology (2024)

Dr. Adamson's research focuses on pediatric pulmonary hypertension, cardiac catheterization protocols, and postoperative chylothorax management. His work includes developing prediction models for early chylothorax detection and evaluating vasopressin's hemodynamic effects in Fontan circulation patients. He has contributed to clinical practice guidelines for progressive pulmonary hypertension in children.

His recent publications emphasize procedural efficiency in outpatient cardiac catheterization, valve repair durability in congenital heart disease, and standardized chylothorax algorithms. He utilizes multicenter collaborative frameworks and retrospective cohort analyses, with methodological approaches including logistic regression, Cox proportional hazards modeling, and consensus-building surveys. Key technical areas include lymphatic interventions, hemodynamic monitoring, and predictive analytics in pediatric cardiology.

In clinical operations, he investigates same-day discharge criteria for pulmonary hypertension patients and optimal timing for advanced therapies. His work addresses practice variations in chylothorax treatment through quality improvement initiatives, including multidisciplinary algorithm development and ex vivo simulation testing for clinical implementation.